GHP Investment Advisors Inc. Increases Stock Holdings in CME Group Inc. (NASDAQ:CME)

GHP Investment Advisors Inc. increased its holdings in CME Group Inc. (NASDAQ:CME) by 3.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,230 shares of the financial services provider’s stock after buying an additional 660 shares during the period. GHP Investment Advisors Inc.’s holdings in CME Group were worth $4,243,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in CME. Capital International Investors grew its position in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its holdings in CME Group by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after buying an additional 43,293 shares during the last quarter. Raymond James & Associates increased its position in CME Group by 3.2% during the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after buying an additional 94,302 shares in the last quarter. Finally, Legal & General Group Plc raised its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently commented on CME shares. Piper Sandler increased their price objective on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday. Finally, Barclays lifted their target price on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $222.07.

CME Group Trading Down 1.5 %

NASDAQ:CME opened at $226.14 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The business’s 50-day moving average is $218.94 and its two-hundred day moving average is $208.89. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $81.43 billion, a PE ratio of 25.73, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.25 earnings per share. Research analysts predict that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.